In-Stent Restenosis Post-Approval Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.
Also called NCT02542267
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 108 participants
- Sponsor
- Registry
-
NCT02542267
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Italy, Sweden
- Registry status
- Completed
Technical summary
Registry record NCT02542267. Allocation not applicable; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2019-07 (actual). Results posted on 2020-08-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- In-Stent Restenosis Post-Approval Study
- Condition
- Peripheral Artery Disease
- Condition
- Vascular Disease
- Intervention (Device)
- Gore VIABAHN Endoprosthesis
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct02542267- Content hash
061a97b4055b6dcd903237ac0c92c7753df2a4525ecb0c21e8983b958af615e8